NCT05143047

Brief Summary

Our objective is to design and test the efficacy of a health-literacy-informed discharge medication counseling intervention in the inpatient setting to reduce medication dosing errors and improve adherence in hospitalized children discharged on a new liquid medication.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
198

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 22, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 19, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 3, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2022

Completed
2 years until next milestone

Results Posted

Study results publicly available

August 19, 2024

Completed
Last Updated

August 19, 2024

Status Verified

March 1, 2024

Enrollment Period

1.2 years

First QC Date

November 19, 2021

Results QC Date

August 18, 2023

Last Update Submit

March 20, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Observed Dosing Accuracy

    Participants (caregivers) will be asked to draw up a dose of their child's liquid medication using the provided oral dosing syringe and send a secure picture of the syringe via myCap (secure phone application designed to collect patient-centered outcomes for research studies) to research study staff. The primary outcome will be assessed as a continuous percent difference from the prescribed dose (in milliliters) documented in the electronic health record. Study staff assessing amount in picture are blinded to group assignment.

    During follow-up survey assessment 48-72 hours following hospital discharge

Secondary Outcomes (5)

  • Reported Dosing Accuracy

    During follow-up survey assessment 48-72 hours following hospital discharge

  • Correct Medication Name

    During follow-up survey assessment 48-72 hours following hospital discharge

  • Correct Medication Indication

    During follow-up survey assessment 48-72 hours following hospital discharge

  • Correct Medication Dose

    During follow-up survey assessment 48-72 hours following hospital discharge

  • Correct Medication Frequency

    During follow-up survey assessment 48-72 hours following hospital discharge

Other Outcomes (3)

  • Correct Medication Duration

    During follow-up survey assessment 48-72 hours following hospital discharge

  • Correct Medication Side Effects

    During follow-up survey assessment 48-72 hours following hospital discharge

  • Correct Medication Storage

    During follow-up survey assessment 48-72 hours following hospital discharge

Study Arms (2)

Control

NO INTERVENTION

Participants in the usual care group will receive standard-of-care discharge communications per unit routine, including counseling regarding prescribed medications and post-discharge instructions, return precautions, and follow-up appointments by the pediatric nursing staff.

Intervention

EXPERIMENTAL

Participants in the intervention group will receive supplementary medication discharge instructions in addition to the standard communications. They will receive instructions on how to submit information and complete study surveys securely through their cellphones during their child's home treatment period.

Behavioral: Medication counseling

Interventions

Participants will receive a customized written medication instruction sheet which includes a picture of an oral dosing syringe indicating the patient's dose as well as a chart showing medication name, dose, route, frequency, duration, next dose due, side effects, and storage information. In addition, participants will be shown how to draw up their child's dose using an oral syringe and then will be asked to practice this task ("show-back"). "Teach-back" will be used to ensure participant's understanding of medication details.

Intervention

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Caregivers of children up to 6 years old who are hospitalized on a general inpatient hospital medicine teams
  • Caregivers must speak English or Spanish
  • Participants' children must be discharged home on new scheduled liquid medication for minimum 3 days.

You may not qualify if:

  • Medication will be administered by home health nurse
  • Child is in state/protected custody
  • Medication prescription is prescribed to pharmacy other than hospital outpatient pharmacy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Monroe Carell Jr. Children's Hospital - Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

Location

Related Publications (1)

  • Carroll AR, Johnson JA, Stassun JC, Greevy RA, Mixon AS, Williams DJ. Health Literacy-Informed Communication to Reduce Discharge Medication Errors in Hospitalized Children: A Randomized Clinical Trial. JAMA Netw Open. 2024 Jan 2;7(1):e2350969. doi: 10.1001/jamanetworkopen.2023.50969.

Results Point of Contact

Title
Alison Carroll, MD, MPH
Organization
Vanderbilt University Medical Center

Study Officials

  • Alison Carroll, MD, MPH

    Vanderbilt University Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Participants are randomized to control or intervention group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Instructor in Pediatrics

Study Record Dates

First Submitted

November 19, 2021

First Posted

December 3, 2021

Study Start

June 22, 2021

Primary Completion

August 20, 2022

Study Completion

August 20, 2022

Last Updated

August 19, 2024

Results First Posted

August 19, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations